NHSE Consultation – PSH

Interim Clinical Policy: Puberty suppressing hormones for children and adolescents who have gender incongruence / dysphoria

CONSULTATION CLOSES 1 NOVEMBER 2023

NHS England are seeking views on the proposed policy. As children and adolescent gender services are currently commissioned from NHS England, this consultation also applies to Wales. See the information below taken from the consultation website:

“NHS England commissions gender incongruence and dysphoria services and the purpose of this consultation is to seek views on a proposed interim clinical policy on puberty suppressing hormones (sometimes referred to as ‘puberty blockers’ or ‘hormone blockers’) for children and adolescents who have gender incongruence or dysphoria.

The policy proposition is that puberty suppressing hormones are not recommended to be available as a routine commissioning option for the treatment of children and adolescents who have gender incongruence or dysphoria.

This public consultation will run for 90 days from 3 August to 1 November 2023.

At the end of the consultation period, all feedback will be considered before the interim clinical policy is published.”